Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
235.50
+3.20
+(1.38%)
As of 8:04:27 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-8,312
-8,312
104,156
-541,274
-641,693
Investing Cash Flow
-116,840
-116,840
-336,350
169,354
-273,300
Financing Cash Flow
294,159
294,159
172,131
425,753
1,247,118
End Cash Position
968,652
968,652
814,884
868,556
822,153
Income Tax Paid Supplemental Data
14,360
14,360
--
--
--
Interest Paid Supplemental Data
67,578
67,578
32,118
45,235
24,657
Capital Expenditure
-34,277
-34,277
-62,211
-72,059
-76,372
Issuance of Debt
--
--
--
1,016,111
500,000
Repayment of Debt
--
--
--
-762,107
--
Free Cash Flow
-42,589
-42,589
41,945
-613,333
-718,065
12/31/2021 - 2/5/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APRE Aprea Therapeutics, Inc.
2.5336
+0.14%
RKVTF RAKOVINA THERAPEUTICS INC
0.0920
0.00%
SLXNW Silexion Therapeutics Corp
0.0600
-13.42%
GALT Galectin Therapeutics Inc.
1.5700
+6.08%
RKV.V Rakovina Therapeutics Inc.
0.1400
-12.50%
INKT MiNK Therapeutics, Inc.
8.95
-2.72%
TECX Tectonic Therapeutic, Inc.
25.28
-1.13%
ABSI Absci Corporation
3.8500
-4.70%
SANA Sana Biotechnology, Inc.
2.6100
+0.77%
KZIA Kazia Therapeutics Limited
0.8514
+1.36%